AstraZeneca UK Limited

Industry / private company


Location: London, United Kingdom (GB) GB

ISNI: 0000000459294381

ROR: https://ror.org/04r9x1a08

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Economic burden of disease and mortality of intracranial haemorrhage under oral FXai: a German claims data analysis (2025) Huttner HB, Scherg F, Kopke K, Schultze M, Kossack N, Gerner ST, Kuramatsu J, Schwab S Journal article Efficacy of radiotherapy combined with atezolizumab or docetaxel in patients with previously treated NSCLC (2024) Xu J, Wang H, Zhang C, Jin SH, Chen X, Tan F, Frey B, et al. Journal article Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage (2024) Connolly SJ, Sharma M, Cohen AT, Demchuk AM, Członkowska A, Lindgren AG, Molina CA, et al. Journal article Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy (2024) Zhou JG, Yang J, Wang H, Wong AHH, Tan F, Chen X, He SS, et al. Journal article Suboptimal monitoring and management in patients with unrecorded stage 3 chronic kidney disease in real-world settings: Insights from REVEAL-CKD (2024) Tangri N, Alvarez CS, Arnold M, Barone S, Cebrián A, Chen H, De Nicola L, et al. Journal article Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy (2024) Baldwin JG, Heuser-Loy C, Saha T, Schelker R, Slavkovic-Lukic D, Strieder N, Hernandez-Lopez I, et al. Journal article Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study (2023) Tangri N, Moriyama T, Schneider M, Virgitti JB, De Nicola L, Arnold M, Barone S, et al. Journal article Mobilizing Patient and Public Involvement in the Development of Real-World Digital Technology Solutions: Tutorial. (2023) Keogh A, Ardle RM, Diaconu MG, Ammour N, Arnera V, Balzani F, Brittain G, et al. Journal article Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY (2023) Balmaña J, Fasching P, Couch FJ, Delaloge S, Labidi-Galy I, O’Shaughnessy J, Park YH, et al. Journal article Design and validation of a multi-task, multi-context protocol for real-world gait simulation (2022) Scott K, Bonci T, Salis F, Alcock L, Buckley E, Gazit E, Hansen C, et al. Journal article
1 2 3 4